The Zaltrap market is witnessing steady growth over the forecast period, supported by increasing demand for personalized oncology treatments, rising investment in cancer biologics.
Read MoreThe Zabdeno market is witnessing steady growth over the forecast period, supported by increasing investments in outbreak preparedness, rising focus on next-generation viral vaccines.
Read MoreThe Yf-Vax market is witnessing steady growth over the forecast period, supported by increasing global travel, climate driven mosquito spread.
Read MoreThe Yescarta market is witnessing steady growth over the forecast period, supported by expansion into additional cancer indications, rising investments in next-generation car constructs.
Read MoreThe Yervoy market is witnessing steady growth over the forecast period, supported by expansion of immunotherapy pipelines, growth of combination regimens.
Read MoreThe Xyntha,Xyntha Solofuse market is witnessing steady growth over the forecast period, supported by increasing adoption of long-term prophylaxis regimens, rising focus on patient self-administration
Read MoreThe Xultophy 100/3.6 market is witnessing steady growth over the forecast period, supported by expansion of combination therapy adoption, increasing demand for simplified diabetes treatment regimens.
Read MoreThe Xolair market is witnessing steady growth over the forecast period, supported by increasing demand for personalized allergy treatments, into additional inflammatory indications.
Read MoreThe Xiaflex market is witnessing steady growth over the forecast period, supported by increasing demand for outpatient biologic treatments, rising focus on reducing surgical interventions.
Read MoreThe Xgeva market is witnessing steady growth over the forecast period, supported by increasing prevalence of metastatic cancers, rising demand for osteoporosis and bone health treatments.
Read More